Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial

BACKGROUND: The androgen receptor (AR) is discussed as a prognostic and/or predictive marker in breast cancer patients. METHODS: AR mRNA expression was analysed by RT-qPCR in breast cancer patients treated in the neoadjuvant TECHNO (n  =  118, HER2-positive) and PREPARE trial (n  =  321, HER2-positi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Cancer
Hlavní autoři: Witzel, Isabell, Loibl, Sibylle, Wirtz, Ralph, Fasching, Peter A., Denkert, Carsten, Weber, Karsten, Lück, Hans-Joachim, Huober, Jens, Karn, Thomas, Mackelenbergh, Marion von, Marmé, Frederik, Schem, Christian, Stickeler, Elmar, Untch, Michael, Müller, Volkmar
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6964685/
https://ncbi.nlm.nih.gov/pubmed/31728025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0630-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky